FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 125 filers reported holding FATE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,964,000 | -81.5% | 50,000 | -73.0% | 0.87% | -80.4% |
| Q2 2021 | $16,056,000 | +5.3% | 185,000 | 0.0% | 4.41% | +23.1% |
| Q1 2021 | $15,253,000 | +1.7% | 185,000 | +12.1% | 3.58% | +7.2% |
| Q4 2020 | $15,003,000 | +87.7% | 165,000 | -17.5% | 3.34% | +44.7% |
| Q3 2020 | $7,994,000 | +86.4% | 200,000 | +60.0% | 2.31% | +104.1% |
| Q2 2020 | $4,289,000 | -14.2% | 125,000 | -44.4% | 1.13% | -14.6% |
| Q1 2020 | $4,997,000 | -7.2% | 225,000 | -18.2% | 1.32% | +29.3% |
| Q4 2019 | $5,382,000 | -1.0% | 275,000 | -21.4% | 1.02% | -26.0% |
| Q3 2019 | $5,436,000 | +344.8% | 350,000 | +366.7% | 1.38% | +432.7% |
| Q3 2018 | $1,222,000 | +156.7% | 75,000 | -15.9% | 0.26% | +21.5% |
| Q3 2015 | $476,000 | – | 89,231 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
| Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
| Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
| Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
| Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
| Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
| DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
| Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
| Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |